Clinical Trial Update: Personalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer Who Achieved Durable Response by Anti-HER2 Treatment (HER2 CR)

View source ↗

Summary

Clinical trial update describing ctDNA-based personalized detection for patients with HER2-positive metastatic breast cancer who achieved durable response to an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Nagoya City University | Conditions: Breast Cancer, Metastatic, HER2 + Breast Cancer | Status: ACTIVE_NOT_RECRUITING